Loading...
XNYS
PRGO
Market cap3.67bUSD
Apr 03, Last price  
26.90USD
1D
-3.62%
1Q
3.66%
Jan 2017
-67.68%
Name

Perrigo Company PLC

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.84
EPS
Div Yield, %
3.08%
Shrs. gr., 5y
0.13%
Rev. gr., 5y
-2.00%
Revenues
4.37b
-6.06%
1,024,098,0001,366,821,0001,447,428,0001,822,131,0002,006,862,0002,268,870,0002,755,029,0003,173,249,0003,539,800,0004,060,800,0004,603,900,0005,280,600,0004,946,200,0004,731,700,0004,837,400,0005,063,300,0004,138,700,0004,451,600,0004,655,600,0004,373,400,000
Net income
-172m
L+1,252.76%
-352,983,00071,400,00073,797,000135,773,000144,049,000222,546,000339,197,000401,613,000441,900,000205,300,000127,900,000-4,012,800,000119,600,000131,000,000146,100,000-162,600,000-130,900,000-130,900,000-12,700,000-171,800,000
CFO
363m
-10.51%
77,644,000126,531,000128,923,000248,307,000258,345,000314,173,000373,961,000513,376,000553,800,000693,500,0001,198,300,000654,900,000698,900,000593,000,000387,800,000636,200,000156,300,000307,300,000405,500,000362,900,000
Dividend
Aug 30, 20240.276 USD/sh
Earnings
May 02, 2025

Profile

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
IPO date
Dec 17, 1991
Employees
8,900
Domiciled in
IE
Incorporated in
IE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑06
Income
Revenues
4,373,400
-6.06%
4,655,600
4.58%
4,451,600
7.56%
Cost of revenue
3,489,500
4,372,300
4,329,400
Unusual Expense (Income)
NOPBT
883,900
283,300
122,200
NOPBT Margin
20.21%
6.09%
2.75%
Operating Taxes
80,000
(3,900)
(8,200)
Tax Rate
9.05%
NOPAT
803,900
287,200
130,400
Net income
(171,800)
1,252.76%
(12,700)
-90.30%
(130,900)
0.00%
Dividends
(152,500)
(149,700)
(142,400)
Dividend yield
4.32%
3.44%
3.11%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
438,700
36,200
Long-term debt
3,581,700
3,978,400
4,259,900
Deferred revenue
368,200
Other long-term liabilities
499,200
387,000
254,800
Net debt
3,022,900
3,573,900
3,486,000
Cash flow
Cash from operating activities
362,900
405,500
307,300
CAPEX
(118,300)
(101,700)
(96,400)
Cash from investing activities
78,800
(77,500)
(1,958,600)
Cash from financing activities
(611,000)
(187,200)
421,600
FCF
890,700
396,300
(12,900)
Balance
Cash
558,800
751,300
600,700
Long term investments
91,900
209,400
Excess cash
340,130
610,420
587,520
Stockholders' equity
4,455,900
4,767,900
4,842,100
Invested Capital
8,060,170
8,788,780
8,969,780
ROIC
9.54%
3.23%
1.59%
ROCE
10.27%
2.93%
1.23%
EV
Common stock shares outstanding
137,400
135,300
134,500
Price
25.71
-20.11%
32.18
-5.60%
34.09
-12.37%
Market cap
3,532,554
-18.87%
4,353,954
-5.04%
4,585,105
-11.77%
EV
6,555,454
7,927,854
8,071,105
EBITDA
1,209,800
642,800
460,800
EV/EBITDA
5.42
12.33
17.52
Interest
187,800
173,800
156,000
Interest/NOPBT
21.25%
61.35%
127.66%